BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 16798220)

  • 21. Which is the Role of Pneumonectomy in the Era of Parenchymal-Sparing Procedures? Early/Long-Term Survival and Functional Results of a Single-Center Experience.
    Janet-Vendroux A; Loi M; Bobbio A; Lococo F; Lupo A; Ledinot P; Magdeleinat P; Roche N; Damotte D; Regnard JF; Alifano M
    Lung; 2015 Dec; 193(6):965-73. PubMed ID: 26411589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
    Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
    Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection.
    Song SW; Lee HS; Kim MS; Lee JM; Kim JH; Nam BH; Zo JI
    Ann Thorac Surg; 2006 Jun; 81(6):1974-81. PubMed ID: 16731116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: evidence for systematic measurement before lung resection.
    Brunelli A; Refai MA; Salati M; Sabbatini A; Morgan-Hughes NJ; Rocco G
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):567-70. PubMed ID: 16481190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lung resection on exercise capacity and on carbon monoxide diffusing capacity during exercise.
    Wang JS; Abboud RT; Wang LM
    Chest; 2006 Apr; 129(4):863-72. PubMed ID: 16608931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lung scintigraphy and ergospirometry in prediction of postoperative course in lung resection candidates with increased risk of postoperative complications].
    Bolliger CT; Wyser C; Roser H; Stulz P; Solèr M; Perruchoud AP
    Pneumologie; 1996 May; 50(5):334-41. PubMed ID: 8710817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD.
    Kim ES; Kim YT; Kang CH; Park IK; Bae W; Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1317-26. PubMed ID: 27366059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lung toxicity of trimodality chemoradiotherapy with mitomycin C, vindesine, and cisplatin followed by surgery for locally advanced non-small cell lung cancer].
    Sawa T; Yoshida T; Ishiguro T; Ogawara M; Kawahara M; Yamamoto S; Yokota S; Maeda H; Asamoto H
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1745-9. PubMed ID: 14619509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative pulmonary function as a predictor of respiratory complications and mortality in patients undergoing lung cancer resection.
    Fujiu K; Kanno R; Suzuki H; Shio Y; Higuchi M; Ohsugi J; Oishi A; Gotoh M
    Fukushima J Med Sci; 2003 Dec; 49(2):117-27. PubMed ID: 15065638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
    Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative complications of pulmonary resection after platinum-based induction chemotherapy for primary lung cancer.
    Muraoka M; Oka T; Akamine S; Tagawa T; Nagayasu T; Tagawa Y; Ayabe H
    Surg Today; 2003; 33(1):1-6. PubMed ID: 12560899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicted versus observed FEV1 and DLCO after major lung resection: a prospective evaluation at different postoperative periods.
    Brunelli A; Refai M; Salati M; Xiumé F; Sabbatini A
    Ann Thorac Surg; 2007 Mar; 83(3):1134-9. PubMed ID: 17307474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chest wall resection for non-small cell lung cancer: A case-matched study of postoperative pulmonary function and quality of life.
    Liu M; Wampfler JA; Dai J; Gupta R; Xue Z; Stoddard SM; Cassivi SD; Jiang G; Yang P
    Lung Cancer; 2017 Apr; 106():37-41. PubMed ID: 28285692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minute ventilation-to-carbon dioxide output (VE/VCO2) slope is the strongest predictor of respiratory complications and death after pulmonary resection.
    Brunelli A; Belardinelli R; Pompili C; Xiumé F; Refai M; Salati M; Sabbatini A
    Ann Thorac Surg; 2012 Jun; 93(6):1802-6. PubMed ID: 22560968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer.
    Samson P; Robinson CG; Bradley J; Lee A; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Puri V; Meyers BF; Crabtree T
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):697-705.e1. PubMed ID: 26410001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
    Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal.
    Burt BM; Kosinski AS; Shrager JB; Onaitis MW; Weigel T
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):19-28, dicussion 28-29.e1. PubMed ID: 24766848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction chemotherapy for T4 centrally located non-small cell lung cancer.
    Rendina EA; Venuta F; De Giacomo T; Ciccone AM; Ruvolo G; Coloni GF; Ricci C
    J Thorac Cardiovasc Surg; 1999 Feb; 117(2):225-33. PubMed ID: 9918961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary function tests as a predictor of quantitative and qualitative outcomes after thoracic surgery for lung cancer.
    Greillier L; Thomas P; Loundou A; Doddoli C; Badier M; Auquier P; Barlési F
    Clin Lung Cancer; 2007 Nov; 8(9):554-61. PubMed ID: 18186960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early and long-term validation of an algorithm assessing fitness for surgery in patients with postoperative FEV₁ and diffusing capacity of the lung for carbon monoxide < 40%.
    Puente-Maestú L; Villar F; González-Casurrán G; Moreno N; Martínez Y; Simón C; Peñalver R; González-Aragoneses F
    Chest; 2011 Jun; 139(6):1430-1438. PubMed ID: 20930005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.